User: TahirAmin Topic: IP
Category: patent-legal-regime :: india
Last updated: Nov 01 2014 01:54 IST RSS 2.0
 
1 to 20 of 2,647    
Pfizer gets breather as IPAB quashes order rejecting patent for arthritis drug 1.11.2014 Top Headlines
In what could be seen as a breather for 'Big Pharma' firms in the country
Also found in: [+]
Successful professionals or rank mercenaries? 30.10.2014 DNA: Bangalore
Successful professionals or rank mercenaries?
Also found in: [+]
Cipla asks government to revoke five patents held by Novartis 30.10.2014 ET: Pharma
Cipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug Onbrez.
Also found in: [+]
Bottle bulbs set to light up Sunderbans 29.10.2014 TOI: Calcutta Times
Cramped shanties with holes for windows — so much so that even daytime looks like evening indoors. Worldwide, such difficult living conditions can be found not only across developing countries but also in pockets of developed ...
Also found in: [+]
Pharmacovigilance body for withdrawal of codeine drug 27.10.2014 All Specials Stories
Codeine sulphate is used to treat mild-to-moderate pain. It acts on certain centres in the brain and spinal cord to offer relief
Also found in: [+]
From think tank to trade reports – IP on the boil, again 26.10.2014 HBL: Home
Close to 10 years after the Indian Patents Act was amended in January 2005, discussions around intellectual property are on the boil again. Last week, the Government set up a think tank t...
Also found in: [+]
Subramanian till recently had opposed India on IPR 25.10.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global ...
Also found in: [+]
DIPP sets up think tank to draft national Intellectual Property Rights policy 24.10.2014 ET: Policy
It will keep the government regularly informed about the developments taking place in IPR cases which have an impact upon India's IPR Policy, it said.
Also found in: [+]
DIPP sets up think tank to draft national IPR policy 24.10.2014 Latest News
The Commerce and Industry Ministry today constituted a six-member think tank to draft the National Intellectual Property Rights Policy.
Also found in: [+]
Pharma companies feel law change can weaken ability to provide low-cost drugs 21.10.2014 ET: Pharma
Indian drugmakers are also concerned about a shift in India’s position on IPR, which they say is being keenly watched by many developing countries.
Also found in: [+]
Discount deewane 20.10.2014 HBL: Opinion
LETTERS TO THE EDITOR Send your letters by email to bleditor@thehindu.co.in or by post to ‘Letters to the Editor’, The Hindu Business Line, Kasturi Buildings, 859-860, Anna Salai, Chennai 600002.
Also found in: [+]
US pharma gets a booster shot 19.10.2014 HBL: Opinion
Thanks to the India-US Intellectual Property Working Group. Here’s how — and why this is bad news for India’s poor
Also found in: [+]
Medical charity accuses US of pushing India to ease patent rules 18.10.2014 ET: Pharma
India's stringent rules for obtaining patents and its $12.2-billion generics industry reduce incentives to produce cutting-edge medicines.
Also found in: [+]
Exclusive: NSA reviewing deal between official, ex-spy agency head 18.10.2014 FirstPost: World

WASHINGTON (Reuters) - The U.S. National Security Agency has launched an internal review of a senior official’s part-time work for a private venture started by former NSA director Keith Alexander that raises questions over the blurring of lines between government and business. Under the arrangement, which was confirmed by Alexander and current intelligence officials, NSA's Chief Technical Officer, Patrick Dowd, is allowed to work up to 20 hours a week at IronNet Cybersecurity Inc, the private firm led by Alexander, a retired Army general and his former boss.

The post Exclusive: NSA reviewing deal between official, ex-spy agency head appeared first on Firstpost.

Also found in: [+]
NSA reviewing deal between official, ex-spy agency head 18.10.2014 TOI: The United States
The US National Security Agency has launched an internal review of a senior official’s part-time work for a private venture started by former NSA director Keith Alexander that raises questions over the blurring of lines between government and ...
Also found in: [+]
US complaints about India's IPR regime are bullying attempts 17.10.2014 ET: Opinion
When Modi visited the US, there was a US-India joint statement that spoke of an annual high-level Intellectual Property Working Group as part of the US-India Trade Policy Forum.
Also found in: [+]
DIPP defers decision on issuance of compulsory licence for cancer drug Dasatinib 16.10.2014 ET: Pharma
“DIPP has sought further information to justify the issuance of a CL under Section 92 of Indian Patents Act,” said an official privy to the matter."
Also found in: [+]
‘India loses out as arbitration seat’ 16.10.2014 Chennai News, Tamil News, Chennai City News, Tamil Nadu News | TOI City News
India is not seen as a preferred seat for international arbitration because of excessive judicial intervention, inordinate delay, high costs and difficulty in enforcing arbitration awards, said Justice A P Shah, chairman, Law Commission of ...
Also found in: [+]
Buzz off, says Delhi to US Trade Representative 15.10.2014 News
The Government of India has told American authorities that it will not cooperate with the out-of-cycle review
Also found in: [+]
Don't dilute patent law, IPR regime: CPI-M 14.10.2014 New Kerala: India News
New Delhi, Oct 14 : The CPI-M Tuesday asked the government not to dilute the existing patent law and IPR regime, saying they had kept prices of drugs down in India.
Also found in: [+]
1 to 20 of 2,647